Levels of adrenomedullin and proadrenomedullin N-terminal 20 peptide in myocardium and aorta of spontaneously hypertensive rats and Wistar-Kyoto rats

( views:67, downloads:0 )
Author:
()
()
()
()
()
()
Journal Title:
ACTA PHYSIOLOGICA SINICA
Issue:
Volume 55, Issue 03, 2003
DOI:
Key Word:
pathophysiology;adrenomedullin;proadrenomedullin N terminal 20 peptide (PAMP);spontaneously hypertensive rat;mRNA

Abstract: In this study, we observed the levels of adrenomedullin (ADM) and proadrenomedullin N-terminal 20 peptide (PAMP) in myocardium and aorta of spontaneously hypertensive rats (SHRs) in comparison with Wistar-kyoto (WKY) rats. Contents of ADM and PAMP were measured by radioimmunoassay (RIA) in plasma, myocardium and aorta. The amount of Pro-ADM mRNA of myocardium and aorta was determined by competitive quantitative reverse transcription polymerase chain reaction (RT-PCR). In SHRs the amounts of Pro-ADM mRNA of myocardium and aorta were 66.7% (P<0.01) and 73% (P<0.01) higher than those in WKY rat, respectively. In SHRs, the levels of ADM in plasma, myocardium and aorta were 29%, 76.7% and 79% (all P<0.01) higher than those in WKY rats, respectively. The level of PAMP in SHRs was increased by 42.5% in plasma (P<0.01), 47.2% in myocardium (P<0.0.1) and 27.3% in aorta (P<0.05) compared to WKY rats, respectively. In addition, the ratio of ADM content to PAMP content in SHRs group was increased compared with that in WKY group (2.0±0.25 vs 1.64±0.3 and 2.2±0.18 vs 1.56±0.28, in myocardium and aorta, respectively, P<0.01). These results suggest that ProADM gene expression is up-regulated and the increase in ADM and PAMP is different in SHRs. The significance of inconsistency of increase in ADM and PAMP in SHRs needs to be further investigated.

  • [1]Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993;192(2): 552-560.
  • [2]Kitamura K, Sakata J, Kangawa K, Kojima M, Matsuo H, Eto T. Cloning and characterization of cDNA encoding a precursor for human adrenomodullin. Biochem Biophys Res Commun 1993;194(2):720-725.
  • [3]Samson WK. Proadrenomedullin-derived peptides. Front Neuroendocrin 1998;19:100-127.
  • [4]Masada K, Nagayama T, Hosokawa A, Yoshida M, Suzuki-Kusaba M, Hisa H, Kimura T, Satoh S. Effects of adrenomedullin and PAMP on adrenal catecholamine release in dogs. Am J Phys 1999;276:R1118-R1124.
  • [5]Qi YF, Tang CS. Interaction among different fragments of the precursor peptide preproadrenomedullin. J Peking University (Health Science Center) 2001;33(4):298-301.
  • [6]T Eto. A review of the biological properties and clinical implications of adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP), hypotensive and vasodilating peptides. Peptides 2001;22:1693-1711.
  • [7]Oie E, Vinge LE, Yndestasd A, Sandberg C, Grogaaard HK, Attramadal H. Induction of a myocardial adrenomedullin signaling system during ischemic heart failure in rats. Circulation 2000;101:415-422.
  • [8]Celi FS, Zenilman ME, Shuldiner AR. A rapid and versatile method to synthesize internal standards for competitive PCR. Nucleic Acids Res 1993;21(4):1047.
  • [9]Qi YF, Bu DF, Niu DD, Shi YR, Wang SH, Pang YZ, Tang CS, Du JB. Effects of different peptide fragments derived from proadrenomedullin on gene expression of adrenomedullin gene. Peptides 2002;23:1141-1147.
  • [10]Siebert PD, Larrick JW. Competitive PCR. Nature 1992;359:557-558.
  • [11]Tsai SJ, Wiltbank MC. Gene cloning and analysis by RT-PCR. In: Siebert PD, Larrick JW ed. Standard Curve Quantitative Competitive RT-PCR (SC-QC-RT-PCR): A Simple Method to Quantify Absolute Concentration of mRNA from Limited Amounts of Sample. Biotechniques Books, Natick, 1998;91-101.
  • [12]Lewis LK, Smith MW, Yandle TG, Tichards AM, Nicholls MG. Adrenomedullin(1-52) measured in human plasma by radioimmunoassay: plasma concentration, adsorption, and storage. Clin Chemistry 1998;44(3):571-577.
  • [13]Samson WK. Adrenomedullin and the control of fluid and electrolyte homeostasis. Annu Rev Physiol 1999;61:363-389.
  • [14]Moody TW,Coy D, Cuttita F, Montuenga LM. Proadrenomedullin NH (2)-terminal 20 peptide (PAMP) and adrenomedullin bind to teratocarcinoma cells. Peptides 2000,21(1):101-107.
  • [15]Inatsu H, Sakata J, Shimokubo T, Kitani M, Nishizono M, Washimine H, Kitamura K, Kangawa K, Matsuo H, Eto T. Distribution and characterization of rat immunoreactive proadrenomedullin N-terminal 20 peptide (PAMP) and augmented cardiac PAMP in spontaneously hypertensive rat. Biochem Mol Biol Int 1996;38(2):365-372.
  • [16]Etoh T, Kato J, Takenaga M, Imamura T, Kitamura K, Kirwaya Y, Eto T. Differential hormonal profiles of adrenomedullin and proadrenomedullin N-terminal 20 peptide in patients with heart failure and effect of treatment on their plasma levels. Clin Cardiol 1999;22:113-117.
  • [17]Shimosawa T, Kanozawa K, Nagasawa R, Mitarai T, Isoda K, Takahashi K, Ando K, Tozawa Y, Nagase M, Sasaki N, Fujita M, Takano K, Iiri T, Fujita T. Adrenomedullin amidation enzyme activities in hypertensive patients. Hypertens Res 2000;23:167-171.
  • [18]Cormier-Regard S, Nguyen SV, Claycomb WC. Adrenomedullin gene expression is developmentally regulated and induced by hypoxia in rat ventricular cardiac myocytes. J Biol Chem 1998;273 (28):17787-17792.
  • [19]Shindo T, Kurihara Y, Nishimatsu H, Moriyama N, Kakoki M, Wang Y, Imai Y, Ebihara A, Kuwaki T, Ju K-H, Minamino N, Kangawa K, Ishikawa T, Fukuda M, Akomoto Y, Kawakami H, Imai T, Morita H, Yazaki Y, Nagai R, Hirata Y, Kurihara H. Vascular abnormalities and elevated blood pressure in mice lacking adrenomedullin gene. Circulation 2001;104:1964-1971.
  • [20]Dobrzynski E, Wang C, Chao J, Chao L. Adrenomedullin gene delivery attenuates hypertension, cardiac remodeling, and renal injury in deoxycorticosterone acetate-salt hypertensive rats. Hypertension 2000;36(6):995-1001.
  • [21]Gumusel B, Chang JK, Hyman A, Lippton H. Adrenotensin: an ADM gene product with the opposite effects of ADM. Life Sci 1995;57(8):PL 87-90.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn